Global pharmaceutical leader Lupin Limited (Lupin) has earned a prestigious Silver Medal from EcoVadis for its exemplary sustainability management across key areas, including Environment, Labor and Human Rights, Ethics, and Sustainable Procurement. This recognition places Lupin among the top 15% of companies evaluated by EcoVadis, a globally trusted provider of business sustainability ratings.
Lupin demonstrated significant progress in its sustainability efforts, improving its EcoVadis score from 51 in 2024 to 69 in 2025, securing its position at the 87th percentile in the latest assessment.
Ramesh Swaminathan, Executive Director, Global CFO, and Head of API Plus SBU at Lupin, expressed pride in this achievement, stating, "This milestone reaffirms our dedication to developing affordable, high-quality pharmaceutical products while maintaining sustainable supply chain practices. Our commitment to environmental responsibility and stakeholder value creation remains unwavering."
Earlier in 2025, Lupin received an “A-” leadership rating from CDP for its exceptional performance in climate change and water security. Additionally, the company’s S&P Global ESG score surged to 76, significantly surpassing the pharmaceuticals sector’s average score of 30.
This recognition further highlights Lupin’s commitment to building a sustainable future while contributing positively to global health and well-being.